Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2005
08/10/2005EP1560571A2 Edible film for relief of cough or symptoms associated with pharyngitis
08/10/2005EP1560568A1 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate
08/10/2005EP1560562A2 Dermastick thickened ointment
08/10/2005EP1551888A4 Terpolymer of maleic acid, maleic anhydride and alkylvinylether
08/10/2005EP1507514A4 Controlled release compositions of estradiol metabolites
08/10/2005EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/10/2005EP1385552A4 Oral delivery method and composition for solid medications or dietary supplements
08/10/2005EP1324760A4 Creatine ester pronutrient compounds and formulations
08/10/2005EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
08/10/2005EP1299114B1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
08/10/2005EP1282447A4 Stable polymeric micelle-type drug composition and method for the preparation thereof
08/10/2005EP1263327B1 Biocompatible material composition adaptable to diverse therapeutic indications
08/10/2005EP1228028B1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
08/10/2005EP1117351B1 Drug delivery systems
08/10/2005EP1089710B1 Injectable pharmaceutical formulations of partricin derivatives
08/10/2005EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis
08/10/2005EP1068306B1 Pentaerythritol lipid derivatives
08/10/2005EP1051189B1 Vaccine formulation comprising sugar-alcohols and low concentrations of anorganic ions
08/10/2005EP0971704B2 Comestible capsules having flavoured coatings
08/10/2005EP0909274B1 Method for purification of erythropoietin binding protein
08/10/2005EP0837883B1 Method of solubilizing, purifying, and refolding protein
08/10/2005CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases
08/10/2005CN1653112A Polymer composite with internally distributed deposition matter
08/10/2005CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof
08/10/2005CN1652823A Device and method for treating conditions of a joint
08/10/2005CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
08/10/2005CN1652813A Pharmaceutical compositions comprising mannose binding lectin
08/10/2005CN1652793A Androgen pharmaceutical composition and method for treating depression
08/10/2005CN1652790A Novel crystalline forms of the anti-cancer compound ZD1839
08/10/2005CN1652783A Compositions and method for treating infection in cattle and swine
08/10/2005CN1652781A Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
08/10/2005CN1652763A Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
08/10/2005CN1652760A Tamsulosin tablets
08/10/2005CN1652756A Matrix type patch containing bronchodilators
08/10/2005CN1652755A Oral suspension of active principle microcapsules
08/10/2005CN1652754A Tasted masked veterinary solid compositions
08/10/2005CN1652752A Naltrexone hydrochloride compositions
08/10/2005CN1652751A A method to improve surface properties of pharmaceutical tablets
08/10/2005CN1652749A Co-grinding process for the preparation of a ternary composition
08/10/2005CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements
08/10/2005CN1651461A Polyethylene glycol modified and recombined human interleukin and its preparation method
08/10/2005CN1651092A Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent
08/10/2005CN1651091A Sodium alginate microglobule blood vessel suppositery containing gynecoiatry medicine and its preparation method
08/10/2005CN1651090A Transmission system of medicine containing trehalose and hyaluronic acid for eye part and its preparation method
08/10/2005CN1651089A Non-toxic ionic liquid, preparation method and its application
08/10/2005CN1651088A Effervescent preparation using alditol as functional ingredient
08/10/2005CN1651005A Chinese medicinal composition containing corrigent and its preparation method
08/10/2005CN1650937A Noontime tea volatile oil-beta cyclo dextrin inclusion compound and its preparation technology
08/10/2005CN1650872A Externally used medicine for treating sexual dysfunction
08/10/2005CN1650866A Encapsulation method of cyclo propanesacia
08/10/2005CN1650857A Coating method of vitamin C
08/10/2005CN1650853A Doxy rhodol magnetic microglobule and its making method
08/10/2005CN1650844A Edible holographic products particularly pharmaceuticals and methods and apparatus for producing same
08/10/2005CN1650837A System and process for releasing encapsulated active ingredients
08/10/2005CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
08/10/2005CN1213774C Technology for preparation of biological dressing material
08/10/2005CN1213767C Topical compositions comprising ascomycins
08/10/2005CN1213756C Veterinary compositions for treatment of parasitic diseases
08/10/2005CN1213754C Beta-carboline pharmaceutical compositions
08/10/2005CN1213751C Formulation of substituted benzimidazoles
08/10/2005CN1213748C Composition containing unionized surfactant and active component and application thereof
08/10/2005CN1213738C High mechanical stability solid oral dosage form with slow releasing function for active composition
08/10/2005CN1213736C Single-shot vaccine formulation
08/10/2005CN1213734C Biologic adhesive composition
08/10/2005CN1213733C Method of preparing stable suspension of insoluble microparticles
08/10/2005CN1213732C Stable pharmaceutical solution formulations for pressurised metered dose inhalers
08/10/2005CN1213721C Cosmetics compositions
08/10/2005CN1213670C Nutritional and pharmaceutical compositions
08/10/2005CN1213659C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and composition containing the same
08/09/2005US6927278 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals
08/09/2005US6927241 Emulsifiers
08/09/2005US6927235 Vaccine composition comprising iron phosphate as vaccine adjuvant
08/09/2005US6927205 Compositions and methods for treatment of psoriasis
08/09/2005US6926914 Proanthocyanidin-containing composition
08/09/2005US6926913 Tetraglycol as a solvent for molecular iodine in the preparation of a topical counter-irritant against skin burns
08/09/2005US6926910 Hydrophobe biomolecular structure
08/09/2005US6926909 Chrono delivery formulations and method of use thereof
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926896 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction
08/09/2005US6926888 producer cell ( encapsulated in a matrix which containing alginates) containing a plasmid that includes a nucleic acid sequence that encodes endostatin, angiostatin, thrombospondin, or prolactin
08/09/2005US6926884 GPIb-lipid bond construct and use thereof
08/09/2005US6926178 Valve with a two-component seal
08/09/2005CA2278785C Process for preparing solid pharmaceutical dosage forms
08/09/2005CA2276445C Transdermal hormone-delivering therapeutic system
08/09/2005CA2178603C Transdermal therapeutical system for preventing poisoning by organophosphoric neurotoxins that consists of a combination of active substances including a parasympathomimetric and a parasympatholytic agent
08/09/2005CA2168012C Polymeric matrices and their uses in pharmaceutical compositions
08/09/2005CA2019676C Particle-mediated transformation of animal somatic cells
08/04/2005WO2005071067A2 Non-animal origin stabilizers and processes for producing the same
08/04/2005WO2005070921A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005WO2005070901A2 Pyrimidyl phosphonate antiviral compounds and methods of use
08/04/2005WO2005070471A2 Articles comprising magnetic material and bioactive agents
08/04/2005WO2005070468A2 Transglutaminase mediated conjugation of peptides
08/04/2005WO2005070467A2 Method of protecting sensitive molecules from a photopolymerizing environment
08/04/2005WO2005070466A2 Liposome composition for delivery of therapeutic agents
08/04/2005WO2005070465A2 Lipid-based dispersions useful for drug delivery
08/04/2005WO2005070457A1 Melphalan prodrugs
08/04/2005WO2005070425A1 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
08/04/2005WO2005070385A1 Medicinal soap
08/04/2005WO2005070235A1 A drink containing ultrafine powder of ginseng and the method thereof
08/04/2005WO2005070026A2 Drug immunoconjugate combination therapy
1 ... 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 ... 1712